The Role of Myc-Induced Protein Synthesis in Cancer
Open accessAbstract
Deregulation in different steps of translational control is an emerging mechanism for cancer formation. One example of an oncogene with a direct role in control of translation is the Myc transcription factor. Myc directly increases protein synthesis rates by controlling the expression of multiple components of the protein synthetic machinery, including ribosomal proteins and initiation factors of translation, Pol III and rDNA. However, the contribution of Myc-dependent increases in protein synthesis toward the multistep process leading to cancer has remained unknown. Recent evidence strongly suggests that Myc oncogenic signaling may monopolize the translational machinery to elicit cooperative effects on cell growth, cell cycle progression, and genome instability as a mechanism for cancer initiation. Moreover, new genetic tools to restore aberrant increases in protein synthesis control are now available, which should enable the dissection of important mechanisms in cancer that rely on the translational machinery. [Cancer Res 2009;69(23):8839–43]
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MYC is a well-established regulator of ribosome biogenesis and protein translation, including cap-dependent translation, and can rewire translational control in tumor cells when overexpressed.
“Notably, MYC is a well-established regulator of ribosome biogenesis and protein translation, including cap-dependent translation, and can rewire translational control in tumor cells when it is overexpressed (29–31).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,383 · see citing works
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · see citing works
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163 · see citing works
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,080 · see citing works
Self-citationColler, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823 · see citing works
How Common Are Extraribosomal Functions of Ribosomal Proteins?
Warner, J. R., & McIntosh, K. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.006 · Cited by 735 · see citing works
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 659 · see citing works
Drosophila myc Regulates Cellular Growth during Development
Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., & Gallant, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81512-3 · Cited by 648 · see citing works
dMyc Transforms Cells into Super-Competitors
Moreno, E., & Basler, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00262-4 · Cited by 597 · see citing works
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C.-N., Fátyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 471 · see citing works
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 445 · see citing works
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A., Zollo, O., Costa, M. J., Kondrashov, N., Rego, E., Rao, P., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 434 · see citing works
Self-citationMyc-dependent regulation of ribosomal RNA synthesis during Drosophila development
Grewal, S., Li, L., Orian, A., Eisenman, R. N., & Edgar, B. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1223 · Cited by 387 · see citing works
c-Myc enhances protein synthesis and cell size during B lymphocyte development
Iritani, B. M., & Eisenman, R. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13180 · Cited by 364 · see citing works
The transcriptional program of a human B cell line in response to Myc.
Schuhmacher, M., Kohlhuber, F., Hölzel, M., Kaiser, C., Burtscher, H., Jarsch, M., Bornkamm, G., Laux, G., Polack, A., Weidle, U., et al. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.2.397 · Cited by 344 · see citing works
C-Myc 5′ untranslated region contains an internal ribosome entry segment
Stoneley, M., Paulin, F., Quesne, J. P. C. L., Chappell, S. A., & Willis, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201763 · Cited by 333 · see citing works
Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1
Pérez‐Roger, I., Kim, S., Griffiths, B. L., Sewing, A., & Land, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5310 · Cited by 327 · see citing works
Identification and Characterization of a Novel Cell Cycle–Regulated Internal Ribosome Entry Site
Cornelis, S., Bruynooghe, Y., Denecker, G., Huffel, S. V., Tinton, S. A., & Beyaert, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80239-7 · Cited by 326 · see citing works
Ribosomal protein L24 defect in Belly spot and tail (<i>Bst</i>), a mouse<i>Minute</i>
Oliver, E. R., Saunders, T. L., Tarlé, S. A., & Glaser, T. (2004) · Development · doi:10.1242/dev.01268 · Cited by 288 · see citing works
Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N., & Schmidt, E. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7358 · Cited by 287 · see citing works
Identification of c-myc responsive genes using rat cDNA microarray.
Guo, Q., Malek, R. L., Kim, H., Chiao, C., He, M., Ruffy, M., Sanka, K., Lee, N. H., Dang, C. V., & Liu, E. T. (2000) · PubMed · Cited by 265 · see citing works
14-3-3σ controls mitotic translation to facilitate cytokinesis
Wilker, E., van Vugt, M. V., Artim, S. C., Huang, P. H., Petersen, C. P., Reinhardt, H., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., et al. (2007) · Nature · doi:10.1038/nature05584 · Cited by 209 · see citing works
Cell cycle activation by c-myc in a Burkitt lymphoma model cell line
Pajic, A., Spitkovsky, D., Christoph, B., Kempkes, B., Schuhmacher, M., Staege, M. S., Brielmeier, M., Ellwart, J. W., Kohlhuber, F., Bornkamm, G. W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6 · Cited by 204 · see citing works
MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation
Poortinga, G., Hannan, K., Snelling, H., Walkley, C. R., Jenkins, A., Sharkey, K., Wall, M., Brandenburger, Y., Palatsides, M., Pearson, R., et al. (2004) · EMBO Journal · doi:10.1038/sj.emboj.7600335 · Cited by 198 · see citing works
Kim, S., Li, Q., Dang, C. V., & Lee, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200372597 · Cited by 187 · see citing works
A role for c-Myc in the regulation of ribosomal RNA processing
Schlosser, I. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg794 · Cited by 183 · see citing works
Cell-cycle-dependent translational control.
Pyronnet, S., & Sonenberg, N. (2001) · Current Opinion in Genetics and Development · doi:10.1016/s0959-437x(00)00150-7 · Cited by 176 · see citing works
Anderson, S. J., Lauritsen, J. P. H., Hartman, M. G., Foushee, A. M. D., Lefebvre, J. M., Shinton, S. A., Gerhardt, B., Hardy, R. R., Oravecz, T., & Wiest, D. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.012 · Cited by 173 · see citing works
Panić, L., Tamarut, S., Sticker-Jantscheff, M., Barkić, M., Solter, D., Uzelac, M., Grabušić, K., & Volarević, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00751-06 · Cited by 135 · see citing works
The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation
Petretti, C., Savoian, M. S., Montembault, É., Glover, D. M., Prigent, C., & Giet, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400639 · Cited by 134 · see citing works
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis
Greasley, P. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.446 · Cited by 126 · see citing works
Iritani, B. M., Delrow, J. J., Grandori, C., Gomez, I. G., Klacking, M., Carlos, L. S., & Eisenman, R. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf492 · Cited by 97 · see citing works
Activation by c-Myc of transcription by RNA polymerases I, II and III
Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., Ramsbottom, B. A., Innes, F., Kantidakis, T., Kerr, E. R., et al. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730141 · Cited by 95 · see citing works
Arabi, A., Rustum, C., Hallberg, E., & Wright, A. P. H. (2003) · Journal of Cell Science · doi:10.1242/jcs.00370 · Cited by 94 · see citing works
CDK11p58 is required for the maintenance of sister chromatid cohesion
Hu, D., Valentine, M. B., Kidd, V. J., & Lahti, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.007963 · Cited by 92 · see citing works
Barkić, M., Crnomarković, S., Grabušić, K., Bogetić, I., Panić, L., Tamarut, S., Brdovčak, M. C., Jerić, I., Vidak, S., & Volarević, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01588-08 · Cited by 92 · see citing works
Tinton, S. A., Schepens, B., Bruynooghe, Y., Beyaert, R., & Cornelis, S. (2004) · Biochemical Journal · doi:10.1042/bj20040963 · Cited by 87 · see citing works
A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors
Schuldiner, O., & Benvenisty, N. (2001) · Oncogene · doi:10.1038/sj.onc.1204459 · Cited by 67 · see citing works
Schorl, C., & Sedivy, J. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0649 · Cited by 51 · see citing works
Boring, L. F., Sinervo, B., & Schubiger, G. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90231-5 · Cited by 22 · see citing works
Piedra, M., Delgado, M. D., Ros, M. A., & León, J. (2002) · PubMed · Cited by 22 · see citing works
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805 · see citing works
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,498 · see citing works
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375 · see citing works
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889 · see citing works
Activation of mTORC2 by Association with the Ribosome
Zinzalla, V., Stracka, D., Oppliger, W., & Hall, M. N. (2011) · Cell · doi:10.1016/j.cell.2011.02.014 · Cited by 648 · see citing works
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Hsu, T. Y. T., Simon, L. M., Neill, N. J., Marcotte, R., Sayad, A., Bland, C. S., Echeverria, G. V., Sun, T., Kurley, S. J., Tyagi, S., et al. (2015) · Nature · doi:10.1038/nature14985 · Cited by 493 · see citing works
ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
Hart, L. S., Cunningham, J. T., Datta, T., Dey, S., Tameire, F., Lehman, S. L., Qiu, B., Zhang, H., Cerniglia, G. J., Bi, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62973 · Cited by 436 · see citing works
Self-citationPan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Schaub, F. X., Dhankani, V., Berger, A. C., Trivedi, M., Richardson, A. B., Shaw, R., Zhao, W., Zhang, X., Ventura, A., Liu, Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.03.003 · Cited by 431 · see citing works
“…observed in experimental systems upon manipulation of MYC levels (Dominguez-Sola et al., 2007; Gomez-Roman et al., 2006; Grandori et al., 2003, 2005; Grewal et al., 2005; Hnisz et al., 2013; Johnston et al., 1999; Moser et al., 2012; Robinson et al., 2009; for a review see Ruggero, 2009).”
Translational Control in Cancer EtiologyPreprint
Ruggero, D. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012336 · Cited by 362 · see citing works
Self-citationMYC and metabolism on the path to cancer
Hsieh, A. L., Walton, Z. E., Altman, B. J., Stine, Z. E., & Dang, C. V. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.003 · Cited by 337 · see citing works
Biomolecular Condensates and Cancer
Boija, A., Klein, I. A., & Young, R. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.003 · Cited by 320 · see citing works
Ribosome biogenesis in disease: new players and therapeutic targets
Jiao, L., Liu, Y., Yu, X., Pan, X., Zhang, Y., Tu, J., Song, Y., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01285-4 · Cited by 317 · see citing works
Pourdehnad, M., Truitt, M., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 288 · see citing works
Self-citationATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression
Tameire, F., Verginadis, I. I., Leli, N. M., Polte, C., Conn, C. S., Ojha, R., Salinas, C. S., Chinga, F., Monroy, A. M., Fu, W., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0347-9 · Cited by 269 · see citing works
Self-citationThe Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc
Prensner, J. R., Chen, W., Han, S., Iyer, M. K., Cao, Q., Kothari, V., Evans, J. R., Knudsen, K. E., Paulsen, M. T., Ljungman, M. E., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.09.001 · Cited by 257 · see citing works
AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate Ribosome Biogenesis in Cancer
Chan, J. C., Hannan, K. M., Riddell, K., Ng, P. Y., Peck, A., Lee, R. S., Hung, S. S. C., Astle, M. V., Bywater, M. J., Wall, M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001754 · Cited by 239 · see citing works
Targeting the nucleolus for cancer intervention
Quin, J. E., Devlin, J. R., Cameron, D. P., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.009 · Cited by 224 · see citing works
Wang, W., Nag, S. A., Zhang, X., Wang, M., Wang, H., Zhou, J., & Zhang, R. (2014) · Medicinal Research Reviews · doi:10.1002/med.21327 · Cited by 223 · see citing works
Cameron, K. S., Buchner, V., & Tchounwou, P. B. (2011) · Reviews on Environmental Health · doi:10.1515/reveh.2011.012 · Cited by 220 · see citing works
Molecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.26 · Cited by 210 · see citing works
Marchingo, J. M., Sinclair, L. V., Howden, A. J. M., & Cantrell, D. A. (2020) · eLife · doi:10.7554/elife.53725 · Cited by 202 · see citing works
Myc proteins as therapeutic targets
Gustafson, W. C., & Weiss, W. A. (2010) · Oncogene · doi:10.1038/onc.2009.512 · Cited by 199 · see citing works
Regulation of let-7 and its target oncogenes (Review)
WANG, X., Cao, L., Wang, Y., Wang, X., Liu, N., & You, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.609 · Cited by 191 · see citing works
Development of a stress response therapy targeting aggressive prostate cancer
Nguyen, H. G., Conn, C. S., Kye, Y., Xue, L., Forester, C. M., Cowan, J. E., Hsieh, A. C., Cunningham, J. T., Truillet, C., Tameire, F., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2036 · Cited by 164 · see citing works
Self-citationJi, H., Wu, G. Y., Zhan, X., Nolan, A., Koh, C. M., Marzo, A. D., Doan, H. M., Fan, J., Cheadle, C., Fallahi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026057 · Cited by 162 · see citing works
Polyamine synthesis as a target of MYC oncogenes
Bachmann, A. S., & Geerts, D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.003336 · Cited by 148 · see citing works
Potential of Stem Cell-Based Therapy for Ischemic Stroke
Marei, H. E. S., Hasan, A., Rizzi, R., Althani, A., Afifi, N. M., Cenciarelli, C., Caceci, T., & Shuaib, A. M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00034 · Cited by 140 · see citing works
Green, A. R., Aleskandarany, M. A., Agarwal, D., Elsheikh, S. E., Nolan, C. C., Diez, M., Macmillan, R. D., Ball, G., Caldas, C., Madhusudan, S., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.46 · Cited by 135 · see citing works
Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
Golomb, L., Bublik, D. R., Wilder, S., Nevo, R., Kiss, V., Grabusic, K., Volarevic, S., & Oren, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.022 · Cited by 137 · see citing works
Widespread Translational Remodeling during Human Neuronal Differentiation
Blair, J. D., Hockemeyer, D. F., Doudna, J. A., Bateup, H. S., & Floor, S. N. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.095 · Cited by 131 · see citing works
Koh, C. M., Gürel, B., Sutcliffe, S. S., Aryee, M. J., Schultz, D., Iwata, T., Uemura, M., Zeller, K. I., Anele, U. A., Zheng, Q., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.040 · Cited by 133 · see citing works
Revisiting the Nucleolus: From Marker to Dynamic Integrator of Cancer Signaling
Ruggero, D. (2012) · Science Signaling · doi:10.1126/scisignal.2003477 · Cited by 129 · see citing works
Self-citationThe ribosome, (slow) beating heart of cancer (stem) cell
Bastide, A., & David, A. (2018) · Oncogenesis · doi:10.1038/s41389-018-0044-8 · Cited by 119 · see citing works
SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation
Vendramin, R., Verheyden, Y., Ishikawa, H., Goedert, L., Nicolas, É., Saraf, K., Armaos, A., Ponti, R. D., Izumikawa, K., Mestdagh, P., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0143-4 · Cited by 123 · see citing works
Ribosome biogenesis and cancer
Derenzini, M., Montanaro, L., & Treré, D. (2017) · Acta Histochemica · doi:10.1016/j.acthis.2017.01.009 · Cited by 119 · see citing works
The cancerous translation apparatus
Stumpf, C. R., & Ruggero, D. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.03.007 · Cited by 116 · see citing works
Self-citationp53 -Dependent and -Independent Nucleolar Stress Responses
Olausson, K. H., Nistér, M., & Lindström, M. S. (2012) · Cells · doi:10.3390/cells1040774 · Cited by 116 · see citing works
Role of let-7 family microRNA in breast cancer
Thammaiah, C. K., & Jayaram, S. (2016) · Non-coding RNA Research · doi:10.1016/j.ncrna.2016.10.003 · Cited by 110 · see citing works
MYC and Transcription ElongationPreprint
Rahl, P. B., & Young, R. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a020990 · Cited by 112 · see citing works
Bu, Y., Yoshida, A., Chitnis, N., Altman, B. J., Tameire, F., Oran, A. R., Gennaro, V. J., Armeson, K. E., McMahon, S. B., Wertheim, G. B. W., et al. (2017) · Nature Cell Biology · doi:10.1038/s41556-017-0006-y · Cited by 108 · see citing works
Self-citationMiluzio, A., Beugnet, A., Grosso, S., Brina, D., Mancino, M., Campaner, S., Amati, B. B., de Marco, A., & Biffo, S. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.018 · Cited by 101 · see citing works
Poortinga, G., Wall, M., Sanij, E., Siwicki, K., Ellul, J., Brown, D. V., Holloway, T. P., Hannan, R. D., & McArthur, G. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1205 · Cited by 98 · see citing works
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
Höllein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F. X., Rudelius, M., Laitinen, I., Nilsson, L. M., Goga, A., Peschel, C., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584524 · Cited by 96 · see citing works
MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and IIIPreprint
Campbell, K. J., & White, R. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018408 · Cited by 95 · see citing works
eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription
Brina, D., Miluzio, A., Ricciardi, S., Clarke, K., Davidsen, P. K., Viero, G., Tebaldi, T., Offenhäuser, N., Rozman, J., Rathkolb, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9261 · Cited by 93 · see citing works
Montanaro, L., Treré, D., & Derenzini, M. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.006 · Cited by 93 · see citing works
Translation factors and ribosomal proteins control tumor onset and progression: how?
Loreni, F., Mancino, M., & Biffo, S. (2013) · Oncogene · doi:10.1038/onc.2013.153 · Cited by 90 · see citing works
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
Zisi, A., Bártek, J., & Lindström, M. S. (2022) · Cancers · doi:10.3390/cancers14092126 · Cited by 80 · see citing works
Hofman, D. A., Ruiz‐Orera, J., Yannuzzi, I., Murugesan, R. A., Brown, A., Clauser, K. R., Condurat, A. L., van Dinter, J. T., Engels, S. A. G., Goodale, A. B., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.003 · Cited by 80 · see citing works
Hui, B., Shi, Y., Ding, Z., Zhou, J., Gu, C., Peng, Y., Yang, H., Liu, W., Shi, G., & Fan, J. (2012) · Cancer · doi:10.1002/cncr.27586 · Cited by 74 · see citing works
Conditional deletion of N‐Myc disrupts neurosensory and non‐sensory development of the ear
Kopecky, B. J., Santi, P. A., Johnson, S. B., Schmitz, H. M., & Fritzsch, B. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22620 · Cited by 70 · see citing works
Ribosome Biogenesis Alterations in Colorectal Cancer
Nait-Slimane, S., Marcel, V., Fenouil, T., Catez, F., Saurin, J., Bouvet, P., Diaz, J., & Mertani, H. C. (2020) · Cells · doi:10.3390/cells9112361 · Cited by 68 · see citing works
Oncogene-regulated release of extracellular vesicles
Kilinc, S., Paisner, R., Camarda, R., Gupta, S., Momčilović, O., Kohnz, R. A., Avşaroğlu, B., L’Étoile, N. D., Perera, R. M., Nomura, D. K., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.05.014 · Cited by 68 · see citing works
Elkady, A. I., Abuzinadah, O. A., Baeshen, N. A., & Rahmy, T. R. (2012) · BioMed Research International · doi:10.1155/2012/614356 · Cited by 66 · see citing works
RetractedGilles, A., Fréchin, L., Natchiar, K., Biondani, G., von Loeffelholz, O., Holvec, S., Malaval, J., Winum, J., Klaholz, B. P., & Peyron, J. (2020) · Cells · doi:10.3390/cells9030629 · Cited by 66 · see citing works
Lamb, R., Harrison, H., Smith, D. L., Townsend, P. A., Jackson, T., Ózsvári, B., Martinez‐Outschoorn, U., Pestell, R. G., Howell, A., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3278 · Cited by 63 · see citing works
Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
Dang, C. V. (2010) · Genes & Cancer · doi:10.1177/1947601910378742 · Cited by 63 · see citing works
Wong, C., Laddha, S. V., Tang, L. H., Vosburgh, E., Levine, A. J., Normant, E., Sandy, P., Harris, C. R., Chan, C. S., & Xu, E. Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.396 · Cited by 60 · see citing works
Vega, M. E., Giroux, V., Natsuizaka, M., Liu, M., Klein–Szanto, A. J., Stairs, D. B., Nakagawa, H., Wang, K. K., Wang, T. C., Lynch, J. P., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.972875 · Cited by 52 · see citing works
Induced Pluripotent Stem Cell-Based Cancer Vaccines
Ouyang, X., Telli, M. L., & Wu, J. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01510 · Cited by 50 · see citing works
Thu, Y. M., Su, Y. R., Yang, J., Splittgerber, R. C., Na, S., Boyd, A., Mosse, C. A., Simons, C., & Richmond, A. J. (2011) · Oncogene · doi:10.1038/onc.2011.427 · Cited by 49 · see citing works
Translational Regulation of Cancer Metastasis
Micalizzi, D. S., Ebright, R. Y., Haber, D. A., & Maheswaran, S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2720 · Cited by 46 · see citing works
The endoplasmic reticulum stress response in prostate cancer
de la Calle, C. M., Shee, K., Yang, H., Lonergan, P. E., & Nguyen, H. G. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00649-3 · Cited by 47 · see citing works
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Antal, C. E., Oh, T. G., Aigner, S., Luo, E., Yee, B. A., Campos, T., Tiriac, H., Rothamel, K. L., Zhang, C., Jiao, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40798-6 · Cited by 40 · see citing works
Cirone, M. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1934811 · Cited by 40 · see citing works
Signaling to the ribosome in cancer—It is more than just mTORC1
Hannan, K. M., Sanij, E., Hein, N., Hannan, R. D., & Pearson, R. B. (2011) · IUBMB Life · doi:10.1002/iub.428 · Cited by 40 · see citing works
Tuntiwechapikul, W., Taka, T., Songsomboon, C., Kaewtunjai, N., Imsumran, A., Makonkawkeyoon, L., Pompimon, W., & Lee, T. R. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1191 · Cited by 40 · see citing works
Mori, T., Ato, S., Knudsen, J. R., Henriquez-Olguin, C., Li, Z., Wakabayashi, K., Suginohara, T., Higashida, K., Tamura, Y., Nakazato, K., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00164.2021 · Cited by 40 · see citing works
Defining the Molecular Basis of Tumor Metabolism: a Continuing Challenge Since Warburg’s Discovery
de Souza, A. C. S., Justo, G. Z., de Araújo, D. R., & Cavagis, A. D. M. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335792 · Cited by 39 · see citing works
Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24
Han, Z., Zhu, S., Han, X., Wang, Z., Wu, S., & Zheng, R. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.10.021 · Cited by 39 · see citing works
Heikkinen, T., Korpela, T., Fagerholm, R., Khan, S., Aittomäki, K., Heikkilä, P., BLOMQVIST, C. P., Carpén, O., & Nevanlinna, H. A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2671-2 · Cited by 38 · see citing works
More than a messenger: Alternative splicing as a therapeutic target
Black, A. J., Gamarra, J. R., & Giudice, J. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.06.006 · Cited by 36 · see citing works
Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.
Gong, Y., Gallis, B. M., Goodlett, D. R., Yang, Y., Lu, H., Lacoste, E., Lai, H. C., & Sasaki, T. (2013) · PubMed · Cited by 38 · see citing works
Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases
Hibaoui, Y., & Féki, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00267 · Cited by 35 · see citing works
Myc, Oncogenic Protein Translation, and the Role of Polyamines
Franson, A. T., & Hogarty, M. D. (2018) · Medical Sciences · doi:10.3390/medsci6020041 · Cited by 35 · see citing works
HSPC111 Governs Breast Cancer Growth by Regulating Ribosomal Biogenesis
Zhang, C., Yin, C., Wang, L., Zhang, S., Yi, Q., Ma, J., Zhang, Z., Xu, Y., & Liu, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0168 · Cited by 34 · see citing works
Li, Y., Su, Y., Zhao, Y., Hu, X., Zhao, G., He, J., Wan, S., Lü, M., & Cui, H. (2021) · MedComm · doi:10.1002/mco2.73 · Cited by 32 · see citing works
Howard, C. M., Estrada, M. D., Terrero, D., Tiwari, A. K., & Raman, D. (2020) · Cancers · doi:10.3390/cancers12082169 · Cited by 31 · see citing works
Ogasawara, R., Knudsen, J. R., Li, J., Ato, S., & Jensen, T. E. (2020) · The Journal of Physiology · doi:10.1113/jp280528 · Cited by 30 · see citing works
Miller, H. D., Clark, B. W., Hinton, D. E., Whitehead, A., Martin, S., Kwok, K. W. H., & Kullman, S. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052479 · Cited by 30 · see citing works
The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
Yan, S., Frank, D. O., Son, J., Hannan, K. M., Hannan, R. D., Chan, K. T., Pearson, R. B., & Sanij, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010210 · Cited by 30 · see citing works
Gomez‐Cadena, A., Barreto, A., Fioretino, S., & Jandus, C. (2020) · Cell Stress · doi:10.15698/cst2020.07.224 · Cited by 29 · see citing works
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
Zitterbart, K., Filková, H., Tomášiková, L., Nečesalová, E., Zambo, I. S., Kantorová, D., Slámová, I., Vranová, V., Žežulková, D., Pešáková, M., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0289-3 · Cited by 27 · see citing works
Attacking a Nexus of the Oncogenic Circuitry by Reversing Aberrant eIF4F-Mediated Translation
Bitterman, P. B., & Polunovsky, V. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0530 · Cited by 26 · see citing works
Rasool, R. U., Rah, B., Amin, H., Nayak, D., Chakraborty, S., Rawoof, A., Mintoo, M. J., Yousuf, K., Mukherjee, D., Kumar, L. D., et al. (2016) · Scientific Reports · doi:10.1038/srep18800 · Cited by 25 · see citing works
LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy
Missios, P., da Rocha, E. L., Pearson, D. S., Philipp, J., Aleman, M. M., Pirouz, M., Farache, D., Franses, J. W., Kubaczka, C., Tsanov, K. M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145142 · Cited by 24 · see citing works
Growth inhibitory effects of large subunit ribosomal proteins in melanoma
Kardos, G. R., Dai, M., & Robertson, G. P. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12259 · Cited by 24 · see citing works
Pourteimoor, V., Paryan, M., & Mohammadi‐Yeganeh, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26399 · Cited by 24 · see citing works
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer
Meena, J. K., Wang, J. H., Neill, N. J., Keough, D. T., Putluri, N., Katsonis, P., Koire, A. M., Lee, H., Bowling, E. A., Tyagi, S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0649 · Cited by 24 · see citing works
Derenzini, M., Montanaro, L., & Treré, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36627 · Cited by 22 · see citing works
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Nardi, F., Perurena, N., Schade, A. E., Li, Z.-H., Ngo, K., Ivanova, E. V., Saldanha, A., Li, C., Gokhale, P. C., Hata, A. N., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167651 · Cited by 21 · see citing works
“NPM1, DKC1, NOP56, RRP1) based on previously published data (29).”
Regulation of Nucleolar Activity by MYC
Brown, I. N., Lafita‐Navarro, M. C., & Conacci‐Sorrell, M. (2022) · Cells · doi:10.3390/cells11030574 · Cited by 21 · see citing works
Devlin, J. R., Hannan, K. M., Ng, P. Y., Bywater, M. J., Shortt, J., Cullinane, C. M., McArthur, G. A., Johnstone, R. W., Hannan, R. D., & Pearson, R. B. (2013) · FEBS Journal · doi:10.1111/febs.12135 · Cited by 21 · see citing works
Bitterman, P. B., & Polunovsky, V. A. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19610 · Cited by 21 · see citing works
Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors
Major, T., Menon, J., Auyeung, G., Soldner, F., Hockemeyer, D. F., Jaenisch, R., & Tabar, V. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024687 · Cited by 21 · see citing works
Paquin, M., Cagnol, S., Carrier, J. C., Leblanc, C., & Rivard, N. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-33 · Cited by 21 · see citing works
Repurposing Tranexamic Acid as an Anticancer Agent
Law, M. E., Davis, B. J., Ghilardi, A. F., Yaaghubi, E., Dulloo, Z. M., Wang, M., Guryanova, O. A., Heldermon, C. D., Jahn, S. C., Castellano, R. K., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.792600 · Cited by 20 · see citing works
Kopecky, B. J., DeCook, R. R., & Fritzsch, B. (2012) · Behavioral Neuroscience · doi:10.1037/a0026896 · Cited by 20 · see citing works
Huang, W., Wang, P., Shen, T., Hu, C., Han, Y., Song, M., Bian, Y., Li, Y., & Zhu, Y. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0880-3 · Cited by 19 · see citing works
Chaturvedi, N. K., Kling, M. J., Griggs, C. N., Kesherwani, V., Shukla, M., McIntyre, E. M., Ray, S., Liu, Y., McGuire, T. R., Sharp, J. G., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0996 · Cited by 20 · see citing works
- Authors
- Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Ruggero, Davide
- ORCID
- Ruggero, Davide
- Venue
- Cancer Research
- Published
- 2009-11-30
- Volume
- 69
- Issue
- 23
- Pages
- 8839-8843
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2880919
- OpenAlex
- W2093199938
- Cited by
- 186
- References
- 42
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 18 · 2013: 13 · 2012: 19
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sandler Foundation
- National Institutes of Health (NIH-R01)
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL085572)
- National Cancer Institute (R01CA140456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- MYC oncogene, translational regulation, protein synthesis, ribosomal proteins, translation initiation factors, ribosomal DNA, genomic instability, cell cycle progression, tumor initiation, translation machinery
- MeSH terms
- Animals, Humans, Neoplasms, Protein Biosynthesis, Gene Expression Regulation, Neoplastic, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review